Exclusive

Publication

Byline

Location

US Patent Issued to KNOA PHARMA on Oct. 27 for "Process for purifying noroxymorphone" (Rhode Island Inventor)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,285, issued on Oct. 27, was assigned to KNOA PHARMA LLC (Stamford, Conn.). "Process for purifying noroxymorphone" was invented by C. Freder... Read More


US Patent Issued to LG CHEM on Oct. 27 for "Compound and organic light emitting device comprising the same" (South Korean Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,286, issued on Oct. 27, was assigned to LG CHEM Ltd. (Seoul, South Korea). "Compound and organic light emitting device comprising the same"... Read More


US Patent Issued to FIMECS on Oct. 27 for "Heterocyclic compound" (Japanese Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,287, issued on Oct. 27, was assigned to FIMECS Inc. (Fujisawa, Japan). "Heterocyclic compound" was invented by Yusuke Tominari (Sagamihara,... Read More


US Patent Issued to CIT THERAPEUTICS on Oct. 27 for "4,5,6,7-tetrahydrothieno[2,3-cpyridine sumo inhibitors and uses thereof" (California Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,288, issued on Oct. 27, was assigned to CIT THERAPEUTICS INC. (La Jolla, Calif.). "4,5,6,7-tetrahydrothieno[2,3-cpyridine sumo inhibitors a... Read More


US Patent Issued to NXERA PHARMA UK on Oct. 27 for "H4 antagonist compounds" (Canadian, British Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,289, issued on Oct. 27, was assigned to NXERA PHARMA UK Ltd. (Great Britain). "H4 antagonist compounds" was invented by Giles Albert Brown ... Read More


US Patent Issued to Vertero Therapeutics on Oct. 27 for "Inhibitors of microbially induced amyloid" (Massachusetts, Connecticut Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,290, issued on Oct. 27, was assigned to Vertero Therapeutics Inc. (Woburn, Mass.). "Inhibitors of microbially induced amyloid" was invented... Read More


US Patent Issued to Grey Wolf Therapeutics on Oct. 27 for "Compounds as modulators of endoplasmic reticulum aminopeptidase 1 (ERAP1)" (British Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,291, issued on Oct. 27, was assigned to Grey Wolf Therapeutics Ltd. (Abingdon, Great Britain). "Compounds as modulators of endoplasmic reti... Read More


US Patent Issued to BP InnoMed on Oct. 27 for "LMP1 targeting lanthanide complexes and methods of use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,292, issued on Oct. 27, was assigned to BP InnoMed Ltd. (Hong Kong). "LMP1 targeting lanthanide complexes and methods of use thereof" was i... Read More


US Patent Issued to IDEMITSU KOSAN on Oct. 27 for "Compound, material for organic electroluminescent element, organic electroluminescent element and electronic device" (Swiss Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,293, issued on Oct. 27, was assigned to IDEMITSU KOSAN Co. LTD. (Tokyo). "Compound, material for organic electroluminescent element, organi... Read More


US Patent Issued to Advanced Material Solutions on Oct. 27 for "Method and system for selective recovery of monochlorosilane and dichlorosilane in polysilicon production process" (Montana Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,294, issued on Oct. 27, was assigned to Advanced Material Solutions LLC. "Method and system for selective recovery of monochlorosilane and ... Read More